Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia

Servatius, Helge Simon; Höfeler, Thormen; Hoffmann, Boris A; Sultan, Arian; Lüker, Jakob; Schäffer, Benjamin; Willems, Stephan; Steven, Daniel (2016). Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia. Europace, 18(8), euv303. Oxford University Press 10.1093/europace/euv303

[img]
Preview
Text
europace.euv303.full.pdf - Published Version
Available under License Publisher holds Copyright.

Download (104kB) | Preview

AIMS

Propofol sedation has been shown to be safe for atrial fibrillation ablation and internal cardioverter-defibrillator implantation but its use for catheter ablation (CA) of ventricular tachycardia (VT) has yet to be evaluated. Here, we tested the hypothesis that VT ablation can be performed using propofol sedation administered by trained nurses under a cardiologist's supervision.

METHODS AND RESULTS

Data of 205 procedures (157 patients, 1.3 procedures/patient) undergoing CA for sustained VT under propofol sedation were analysed. The primary endpoint was change of sedation and/or discontinuation of propofol sedation due to side effects and/or haemodynamic instability. Propofol cessation was necessary in 24 of 205 procedures. These procedures (Group A; n = 24, 11.7%) were compared with those with continued propofol sedation (Group B; n = 181, 88.3%). Propofol sedation was discontinued due to hypotension (n = 22; 10.7%), insufficient oxygenation (n = 1, 0.5%), or hypersalivation (n = 1, 0.5%). Procedures in Group A were significantly longer (210 [180-260] vs. 180 [125-220] min, P = 0.005), had a lower per hour propofol rate (3.0 ± 1.2 vs. 3.8 ± 1.2 mg/kg of body weight/h, P = 0.004), and higher cumulative dose of fentanyl administered (0.15 [0.13-0.25] vs. 0.1 [0.05-0.13] mg, P < 0.001), compared with patients in Group B. Five (2.4%) adverse events occurred.

CONCLUSION

Sedation using propofol can be safely performed for VT ablation under the supervision of cardiologists. Close haemodynamic monitoring is required, especially in elderly patients and during lengthy procedures, which carrying a higher risk for systolic blood pressure decline.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Kardiologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Kardiologie

UniBE Contributor:

Servatius, Helge Simon (A)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1099-5129

Publisher:

Oxford University Press

Language:

English

Submitter:

Helge Simon Servatius

Date Deposited:

19 Jul 2016 11:32

Last Modified:

29 Mar 2023 23:34

Publisher DOI:

10.1093/europace/euv303

PubMed ID:

27247017

Uncontrolled Keywords:

Adverse events; Catheter ablation; Propofol; Sedation; Ventricular tachycardia

BORIS DOI:

10.7892/boris.83857

URI:

https://boris.unibe.ch/id/eprint/83857

Actions (login required)

Edit item Edit item
Provide Feedback